These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 31859763

  • 21. [Taurolidine for the prevention of catheter-related infections in children with intestinal insufficiency: preliminary experience in a Chilean tertiary hospital].
    Jordán P M, Haro C, Puchi A.
    Rev Chilena Infectol; 2021 Feb; 38(1):15-21. PubMed ID: 33844787
    [Abstract] [Full Text] [Related]

  • 22. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y, Roosenboom B, Causevic E, Kievit W, Groenewoud H, Wanten GJA.
    Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
    [Abstract] [Full Text] [Related]

  • 23. Do we know the benefits of a taurolidine lock in adult home parenteral nutrition patients with a low infection rate?
    Olthof ED, Broekman MM, Wanten GJ.
    JPEN J Parenter Enteral Nutr; 2015 May; 39(4):385. PubMed ID: 25883235
    [No Abstract] [Full Text] [Related]

  • 24. Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients.
    Clark JE, Graham N, Kleidon T, Ullman A.
    Pediatr Infect Dis J; 2019 Jan; 38(1):e16-e18. PubMed ID: 30204661
    [Abstract] [Full Text] [Related]

  • 25. In vitro activity of taurolidine against clinical Candida auris isolates: relevance to catheter-related bloodstream infections.
    Reidenberg BE, Jenkins SG, Crandon JL, Hurlburt E, Tan X, Rhomberg PR, Arends SJR, Pfaffle A.
    Antimicrob Agents Chemother; 2024 Jul 09; 68(7):e0038124. PubMed ID: 38864612
    [Abstract] [Full Text] [Related]

  • 26. The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis.
    van den Bosch CH, Jeremiasse B, van der Bruggen JT, Frakking FNJ, Loeffen YGT, van de Ven CP, van der Steeg AFW, Fiocco MF, van de Wetering MD, Wijnen MHWA.
    J Hosp Infect; 2022 May 09; 123():143-155. PubMed ID: 34767871
    [Abstract] [Full Text] [Related]

  • 27. The best solution down the line: an observational study on taurolidine- versus citrate-based lock solutions for central venous catheters in hemodialysis patients.
    van Roeden S, van Oevelen M, Abrahams AC, Dekker FW, Rotmans JI, Meijvis SCA, DUCATHO study group.
    BMC Nephrol; 2021 Sep 13; 22(1):308. PubMed ID: 34517829
    [Abstract] [Full Text] [Related]

  • 28. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG, van Agteren M.
    Nephrol Dial Transplant; 2004 Jun 13; 19(6):1546-51. PubMed ID: 14993498
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mechanical Complications in Central Lines Using Taurolidine Versus Ethanol Lock Therapy in Children With Intestinal Failure.
    Strauss J, Boctor DL, Silverman JA, Casey L.
    J Pediatr Gastroenterol Nutr; 2022 Jun 01; 74(6):776-781. PubMed ID: 35213858
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition.
    Williams TJ, Moy N, Kaazan P, Callaghan G, Holtmann G, Martin N.
    JPEN J Parenter Enteral Nutr; 2024 Feb 01; 48(2):165-173. PubMed ID: 38062902
    [Abstract] [Full Text] [Related]

  • 35. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
    Longo R, Llorens M, Goetz C, Platini C, Eid N, Sellies J, Ouamara N, Quétin P.
    Oncology; 2017 Feb 01; 93(2):99-105. PubMed ID: 28463827
    [Abstract] [Full Text] [Related]

  • 36. Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties.
    Piątkowska E, Paleczny J, Dydak K, Letachowicz K.
    PLoS One; 2021 Feb 01; 16(10):e0258148. PubMed ID: 34618850
    [Abstract] [Full Text] [Related]

  • 37. Clinical and economic impact of the taurolidine lock on home parenteral nutrition.
    Arnoriaga Rodríguez M, Pérez de Ciriza Cordeu M, Camblor Álvarez M, Bretón Lesmes I, Motilla de la Cámara M, Velasco Gimeno C, Arhip L, García Peris P, Cuerda Compés C.
    Nutr Hosp; 2018 Jun 28; 35(4):761-766. PubMed ID: 30070861
    [Abstract] [Full Text] [Related]

  • 38. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
    Bisseling TM, Willems MC, Versleijen MW, Hendriks JC, Vissers RK, Wanten GJ.
    Clin Nutr; 2010 Aug 28; 29(4):464-8. PubMed ID: 20061070
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.